Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The Dermatological Drugs Market Valuation Change Between Now And 2029?

In recent times, there has been a steady increase in the dimensions of the dermatological drugs market. It is projected to expand from $20.06 billion in 2024 to $21.98 billion in 2025, with a compound annual growth rate (CAGR) of 9.5%. The surge during the historical period is credited to a rise in the incidence of skin conditions, improvements in drug formulation and delivery, an increased understanding of skincare and aesthetics, the growing aging population, and an escalating demand for dermatological products available over the counter.

It’s predicted that the dermatological drugs market will witness substantial growth in the near future. The market size is anticipated to inflate to $31.49 billion by 2029, with a compound annual growth rate (CAGR) of 9.4%. This growth during the forecast period is linked to developments in biologics and targeted therapies, the rising prevalence of skin conditions related to lifestyle, the use of teledermatology and digital health, increased demand for personalized and regenerative medicine, as well as further research in dermatological treatments based on microbiomes. The forecast period will also see significant trends such as drug delivery through nanotechnology, dermatological diagnostics guided by AI, therapies that target microbiomes, skin regeneration via 3D bioprinting, and treatments involving gene editing and RNA.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21166&type=smp

What Underlying Factors Are Supporting The Dermatological Drugs Market Growth?

The dermatological drugs market is set for growth, largely fueled by the uptick in demand for cosmetic dermatology procedures. Cosmetic dermatology, a specific subdivision focusing on improving physical appearances through non-surgical treatments, is seeing a surge in interest. This can be attributed to heightened consumer knowledge of aesthetic procedures, advancements in skincare technology, and a preference for non-invasive procedures for aesthetic enhancement and aging prevention. The demand for procedures like anti-aging and skin rejuvenation treatments are pushing for the development of superior dermatological drugs, providing safe, efficient, and minimally invasive solutions. For example, statistics from the International Society of Aesthetic Plastic Surgery in January 2023 reported over 12.8 million surgical and 17.5 million non-surgical operations globally, showing a 19.3% increase compared to the last reporting period. Furthermore, it is forecasted that in 2022, over 14.9 million surgical and 18.8 million non-surgical procedures will be carried out worldwide, marking an 11.2% rise. Therefore, the increase in cosmetic dermatology procedures is stimulating the dermatological drugs market’s growth.

Which Sub-Segments Are Driving Growth Within The Dermatological Drugs Market?

The dermatological drugsmarket covered in this report is segmented –

1) By Drug Class: Corticosteroids; Retinoids; Antibiotics; Antifungals; Calcineurin Inhibitors; Other Drug Classes

2) By Administration: Topical Administration; Oral Administration; Parenteral Administration

3) By Indication: Acne; Psoriasis; Rosacea; Alopecia; Other Indications

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels

Subsegments:

1) By Corticosteroids: Topical Corticosteroids; Oral Corticosteroids; Injectable Corticosteroids

2) By Retinoids: Topical Retinoids; Oral Retinoids

3) By Antibiotics: Topical Antibiotics; Oral Antibiotics

4) By Antifungals: Topical Antifungals; Oral Antifungals

5) By Calcineurin Inhibitors: Topical Calcineurin Inhibitors; Systemic Calcineurin Inhibitors

6) By Other Drug Classes: Biologics; JAK Inhibitors; Antihistamines; Photodynamic Therapy Agents

What Future-Focused Trends Are Anticipated In The Dermatological Drugs Market?

Major companies involved in the dermatological drugs market are concentrating on creating biologic treatments to better manage chronic skin disorders like psoriasis, atopic dermatitis, and hidradenitis suppurativa. These biologics work by targeting specific immune responses, providing more lasting and effective relief than traditional treatments. For example, in September 2024, Eli Lilly and Company, a pharmaceutical firm based in the US, secured approval for Ebglyss (lebrikizumab), an IL-13 inhibitor aimed at treating moderate-to-severe atopic dermatitis in individuals aged 12 and above. This development provides a new option for patients unresponsive to topical treatments, aiming to alleviate severe itching and inflammation and enhance life quality.

Which Companies Hold A Competitive Edge In The 1401 Market?

Major companies operating in the dermatological drugs market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Bausch Health Companies Inc., Organon International, Galderma, Incyte Corporation, Glenmark Pharmaceuticals Ltd., Mayne Pharma Group Limited, Dermavant Sciences Inc., Taro Pharmaceutical Industries Ltd., Biofrontera AG, Almirall SA, UCB SA, LEO Pharma A/S, Dermira Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/dermatological-drugs-global-market-report

Which Region Dominates The Dermatological Drugs Market Today?

North America was the largest region in the dermatological drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermatological drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21166&type=smp

Browse Through More Reports Similar to the Global Dermatological Drugs Market 2025, By The Business Research Company

Dermatology Medical Lasers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-medical-lasers-global-market-report

Dermatology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-devices-global-market-report

Veterinary Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-dermatology-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model